Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects
NCT ID NCT07680751
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, and quality of life, while also collecting blood samples for future research. The goal is to better understand the long-term course of the disease under current treatments and identify factors that may predict complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could reveal better ways to manage cystinosis and identify biomarkers that predict complications, potentially improving long-term care.
What could go wrong
As an observational study, it does not test a new treatment, so it cannot directly lead to a cure or new therapy. Results may take years to influence clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTINOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
AP-HP_ Hôpital Charles Foix
Ivry-sur-Seine, Île-de-France Region, 94200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••